Genetic variation in vitamin D-related genes and risk of breast cancer among women of European and East Asian descent
Studies of vitamin D-related genetic variants and breast cancer have been inconsistent. This study aimed to investigate associations of vitamin D-related polymorphisms and breast cancer risk among European and East Asian women and potential interactions with menopausal status and breast tumour subtypes. Data from a case–control study of breast cancer (1037 cases and 1050 controls) were used to assess relationships between 21 polymorphisms in two vitamin D-related genes (GC and VDR) and breast cancer risk. Odds ratios were calculated in stratified analyses of European and East Asian women, using logistic regression in an additive genetic model. An interaction term was used to explore modification by menopausal status. Polytomous regression was used to assess heterogeneity by breast tumour subtype. False discovery rate adjustments were conducted to account for multiple testing. No association was observed between GC or VDR polymorphisms and breast cancer risk. Modification of these relationships by menopausal status was observed for select polymorphisms in both Europeans (VDR rs4328262 and rs11168292) and East Asians (GC rs7041 and VDR rs11168287). Heterogeneity by tumour subtype was seen for three VDR polymorphisms (rs1544410, rs7967152 and rs2239186) among Europeans, in which associations with ER−/PR−/HER2+ tumours, but not with other subtypes, were observed. In conclusion, associations between vitamin D-related genetic variants and breast cancer were not observed overall, although the relationships between vitamin D pathway polymorphisms and breast cancer may be modified by menopausal status and breast tumour subtype.
KeywordsVitamin D-related genes Polymorphisms Breast cancer Tumour subtype Case–control
The authors thank all participants for their contribution to this research study. We are grateful for the assistance from Dr. Linda Warren, Dr. Philip Switzer, Caroline Speers, the BC Cancer Registry, the Screening Mammography Program of BC, Agnes Bauzon, Alegria Imperial, Betty Hall, Lina Hsu, Maria Andrews, Teresa Pavlin, Dr. Ross Walker, Dr. Ralph George, Celine Morissette, Jane Warner, Hilary Rimmer, Meghan Hamel and Annie Langley with participant recruitment and data collection in Vancouver and Kingston. The authors thank the genotyping services provided by the McGill University and Genome Quebec Innovation Centre, Montreal, Canada.
Compliance with ethical standards
Conflicts of interest
The Canadian Breast Cancer Study was supported by the Canadian Institutes of Health Research (Grant #69036).
- 1.Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian cancer statistics 2014. Toronto: Canadian Cancer Society; 2014.Google Scholar
- 3.Pilon C, Urbanet R, Williams TA, Maekawa T, Vettore S, Sirianni R, et al. 1α,25-dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: a model for a protective role of vitamin D receptor against adrenocortical cancer. J Steroid Biochem Mol Biol. 2014;140:26–33.CrossRefPubMedGoogle Scholar
- 16.Brunner RL, Wactawski-Wende J, Caan BJ, Cochrane BB, Chlebowski RT, Gass MLS, et al. The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women’s Health Initiative (WHI) Calcium Plus Vitamin D randomized clinical trial. Nutr Cancer. 2011;63:827–41.CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, et al. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer Epidemiol Biomarkers Prev. 2008;17:1339–43.CrossRefPubMedGoogle Scholar
- 28.Dorjgochoo T, Delahanty R, Lu W, Long J, Cai Q, Zheng Y, et al. Common genetic variants in the vitamin D pathway including genome-wide associated variants are not associated with breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev. 2011;20:2313–6.CrossRefPubMedPubMedCentralGoogle Scholar
- 34.Luo S, Guo L, Li Y, Wang S. Vitamin D receptor gene ApaI polymorphism and breast cancer susceptibility: a meta-analysis. Tumor Biol. 2014;35:785–90.Google Scholar
- 35.Shan J, Dai N, Yang X, Qian C, Yang Z, Jin F, et al. FokI polymorphism in vitamin D receptor gene and risk of breast cancer among Caucasian women. Tumor Biol. 2014;35:3503–8.Google Scholar
- 43.Rothman KJ, Greenland S, Lash TL. Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins; 2008.Google Scholar
- 44.Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57:289–300.Google Scholar
- 46.Reimers LL, Crew KD, Bradshaw PT, Santella RM, Steck SE, Sirosh I, et al. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk. Cancer Causes Control. 2015;26:187–203.Google Scholar
- 50.McKay JD, McCullough ML, Ziegler RG, Kraft P, Saltzman BS, Riboli E, et al. Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2009;18:297–305.CrossRefPubMedGoogle Scholar